IPO registrations (S-1, F-1) · Registrants
bioAffinity Technologies, Inc.
- SEC CIK
- 1712762 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2022-04-25, last 2026-06-16; 11 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2022-09-02; declared effective 2022-08-29; withdrawal requested 2023-09-25
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, San Antonio, TX 78217
- EIN
- 46-5211056
- Ticker
- BIAF, BIAFW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- bioAffinity Technologies, Inc. on the corporate pages
Offering terms
- Proposed price range
- $6.00–$6.25 per share (S-1/A filed 2022-08-18)
- Final price
- $6.12 per share, within the range (424B4 filed 2022-09-02, an initial public offering)
- Shares sold
- 1,282,600
- Gross proceeds
- $7,855,925 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BIAF
- Lead underwriters
- WallachBeth Capital
- Syndicate
- Capital Management LLC; Technologies, Inc; of Contents; Craft Capital; Number of Units WallachBeth Capital, LLC (956,069); ViewTrade (326,531)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIOAFFINITY TECHNOLOGIES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: BIOAFFINITY TECHNOLOGIES INC EXACT (EIN (EXACT))
- Form D issuer: bioAffinity Technologies, Inc. EXACT (CIK (EXACT))
- SEC filer: bioAffinity Technologies, Inc. EXACT (CIK (EXACT))
- Person page: Gary D Rubin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
Filings 41
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-04-25 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-22-010771 ↗ |
| 2022-05-25 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-014997 ↗ |
| 2022-06-16 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-016924 ↗ |
| 2022-07-28 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-020463 ↗ |
| 2022-08-02 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-021028 ↗ |
| 2022-08-05 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-021392 ↗ |
| 2022-08-18 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-22-023475 ↗ |
| 2022-08-29 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-22-002533 ↗ |
| 2022-09-02 | 424B4 | 424B4 (final prospectus) | bioAffinity Technologies, Inc. | 0001493152-22-024949 ↗ |
| 2023-09-20 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-23-033238 ↗ |
| 2023-09-25 | RW | RW (withdrawal request) | bioAffinity Technologies, Inc. | 0001493152-23-033516 ↗ |
| 2023-11-27 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-23-003449 ↗ |
| 2024-04-04 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-24-013214 ↗ |
| 2024-04-05 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-24-000868 ↗ |
| 2024-04-15 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-24-000989 ↗ |
| 2024-09-11 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-24-035849 ↗ |
| 2024-09-19 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-24-002903 ↗ |
| 2024-11-27 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-24-048047 ↗ |
| 2024-12-06 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-24-003699 ↗ |
| 2025-04-11 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001641172-25-003892 ↗ |
| 2025-04-18 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-001154 ↗ |
| 2025-05-02 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001641172-25-008170 ↗ |
| 2025-05-05 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001641172-25-008629 ↗ |
| 2025-05-05 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-001428 ↗ |
| 2025-05-07 | 424B4 | 424B4 (final prospectus) | bioAffinity Technologies, Inc. | 0001641172-25-008977 ↗ |
| 2025-07-03 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-002154 ↗ |
| 2025-07-03 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-002160 ↗ |
| 2025-08-29 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001641172-25-025990 ↗ |
| 2025-09-15 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-25-013294 ↗ |
| 2025-09-16 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-002977 ↗ |
| 2025-09-24 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-25-014730 ↗ |
| 2025-09-25 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-25-014878 ↗ |
| 2025-09-29 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-25-003154 ↗ |
| 2025-09-30 | 424B4 | 424B4 (final prospectus) | bioAffinity Technologies, Inc. | 0001493152-25-016338 ↗ |
| 2026-04-30 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-26-020725 ↗ |
| 2026-05-12 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-26-001591 ↗ |
| 2026-06-12 | S-1 | S-1 (registration) | bioAffinity Technologies, Inc. | 0001493152-26-028507 ↗ |
| 2026-06-16 | S-1/A | S-1/A (amendment) | bioAffinity Technologies, Inc. | 0001493152-26-028877 ↗ |
| 2026-06-16 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-26-002028 ↗ |
| 2026-06-18 | 424B4 | 424B4 (final prospectus) | bioAffinity Technologies, Inc. | 0001493152-26-029206 ↗ |
| 2026-09-04 | EFFECT | EFFECT (declared effective) | bioAffinity Technologies, Inc. | 9999999995-26-002900 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-18 | S-1/A | registration statement | $6.00–$6.25 | $7.35 | 1,285,325 | $9,447,138 | Nasdaq BIAF | 5 | primary document; range, price line, shares headline, proceeds computed, cover names 5 | document ↗ |
| 2022-09-02 | 424B4 | final prospectus | $6.12 | 1,282,600 | $7,855,925 | Nasdaq BIAF | 7 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Harvey Sandler Revocable Trust | TenPercentOwner | 6 | 2022–2024 | ||
| Rubin Gary D | Director,TenPercentOwner | 6 | 2022–2024 | person page Fuzzy | |
| GIRGENTI STEVEN | Director; Director,Officer | Executive Chairman | 11 | 2022–2025 | |
| Rebel Vivienne I | Officer | Chief Sci. & Med. Officer, EVP; EVP, Chief Sci. & Med. Officer | 3 | 2022–2024 | |
| Zannes Maria | Director,Officer; Officer | President & CEO; President, CEO | 9 | 2022–2025 | |
| Edwards James Michael | Officer | Chief Financial Officer; Interim CFO; VP and CFO | 5 | 2022–2025 | |
| Anderson Robert A. | Director | 7 | 2022–2024 | ||
| DIAMOND STUART | Director | 6 | 2022–2024 | ||
| KNIGHT PETER S | Director | 6 | 2022–2024 | ||
| Zannes Timothy P | Officer | Secretary, EVP, Gen. Counsel | 5 | 2022–2025 | |
| Meghji Mohsin Y | Director | 4 | 2023–2024 | ||
| Perlmutter Nathan M | TenPercentOwner | 2 | 2023 | ||
| Dougherty Michael Philip | Officer | Chief Financial Officer | 3 | 2023–2024 | |
| Reveles Xavier Trinidad | Officer | Chief Operating Officer | 3 | 2023–2025 | |
| Joyce Roby | Director | 4 | 2023–2024 | ||
| Platt Jamie | Director | 4 | 2023–2024 | ||
| Joyce Living Trust | Other | 1 | 2024 | ||
| Oppenheimer John J. | Director | 1 | 2025 | ||
| Rios Roberto | Director | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-29 | bioAffinity Technologies, Inc. | Biotechnology | $3,994,173 | $0 | 5 | 1 |
| 2024-08-12 | bioAffinity Technologies, Inc. | Biotechnology | $1,302,084 | $1,302,084 | 3 | 1 |
| 2024-08-12 | bioAffinity Technologies, Inc. | Biotechnology | $450,000 | $450,000 | 3 | 1 |
| 2024-03-20 | bioAffinity Technologies, Inc. | Biotechnology | $2,624,000 | $2,624,000 | 3 | 1 |
| 2017-07-26 | bioAffinity Technologies, Inc. | Biotechnology | $4,047,993 | $4,047,993 | 39 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BIOAFFINITY TECHNOLOGIES, INC. | TX | State business registries | name and state |
| Form D issuer | bioAffinity Technologies, Inc. | TX | Form D private offerings | CIK (EXACT) |
| Patent assignee | bioAffinity Technologies, Inc. | TX | Patents (USPTO) | name and state |
| SEC filer | bioAffinity Technologies, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | bioAffinity Technologies, Inc. | TX | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | BIOAFFINITY TECHNOLOGIES INC | EIN (EXACT) | ||
| Person page | Gary D Rubin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.